Search 33,000+ CME courses
Back

StatPearls, LLC

  • Calcium Channel Blockers
  • Infusions, Intravenous
  • Nimodipine
  • Subarachnoid Hemorrhage

Nimodipine

Nimodipine is a second-generation 1,4-dihydropyridine calcium channel blocker that was originally approved by the FDA to manage hypertension. Today, nimodipine is predominantly used to manage vasospasm subsequent to subarachnoid hemorrhage, in addition to off-label applications. Nimodipine is available in various formulations, including oral tablets, solutions, and intravenous infusions. This discussion will primarily focus on this medication’s administration methods and associated considerations. Equally important are the indications, mechanisms of action, adverse effects, contraindications, and monitoring associated with nimodipine administration. Healthcare professionals must have a deep comprehension of this medication in order to use it effectively. This informed decision-making not only optimizes dosage regimens but also mitigates adverse reactions, facilitating enhanced patient outcomes in subarachnoid hemorrhage scenarios treated with nimodipine.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABOHNS — Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 10 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one